Detalhe da pesquisa
1.
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Cytokine
; 164: 156143, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774730
2.
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Exp Parasitol
; 251: 108555, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247802
3.
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Parasitol Res
; 122(12): 2917-2931, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768367
4.
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection.
Cytokine
; 153: 155865, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339043
5.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog
; 162: 105341, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883228
6.
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis.
Parasite Immunol
; 44(8): e12921, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437797
7.
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Microb Pathog
; 151: 104745, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485994
8.
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Med Microbiol Immunol
; 210(2-3): 133-147, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870453
9.
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitology
; 148(13): 1706-1714, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060464
10.
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Cell Immunol
; 356: 104194, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32827943
11.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog
; 147: 104283, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485231
12.
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Parasite Immunol
; 42(12): e12784, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772379
13.
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
Exp Parasitol
; 216: 107941, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622940
14.
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
Microb Pathog
; 137: 103783, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600536
15.
A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies.
Sci Rep
; 13(1): 4345, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927952
16.
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis.
Pathogens
; 12(2)2023 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36839586
17.
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
Biology (Basel)
; 12(6)2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37372136
18.
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice.
Acta Trop
; 246: 106986, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453579
19.
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasis.
Mol Immunol
; 155: 79-90, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36731193
20.
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from Patients.
Viruses
; 15(9)2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766284